Vitamin D and sarcoidosis

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 5, 2010, Pages 487-488

  Sharma, Om P ^a  

^a Department of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D;

DISEASE SEVERITY; HUMAN; HUMAN CELL; IMMUNOMODULATION; INCIDENCE; INNATE IMMUNITY; LUNG LAVAGE; LUNG SARCOIDOSIS; LUNG TUBERCULOSIS; MACROPHAGE ACTIVATION; MONOCYTE; NOTE; RISK FACTOR; VITAMIN D DEFICIENCY;

HUMANS; RISK FACTORS; SARCOIDOSIS, PULMONARY; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77955253255     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32833cbc81     Document Type: Note

References (13)

1. Adams J, Sharma O, Gacad M, Singer F. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest 1983; 72:1856-1860.
2. Adams J, Hewison M. Update in Vitamin D. J Clin Endocrinol Metab 2010; 95:471-478.
3. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin Dmediated human antimicrobial response. Science 2006; 311:1770-1773.
4. Rook GA, Steele J, Fraher L, et al. Vitamin D3, interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986; 57:159-163.
5. Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008; 37:113-119.
6. Ginde AA, Liu MC, Camargo CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009; 169:626-632.
7. Edmondstone WM, Wilson AG. Sarcoidosis in Caucasians, Blacks, and Asians. Br J Dis Chest 1985; 79:27-36.
8. Benatar SR. Sarcoidosis in South Africa: a comparative study in Whites, Blacks, and Coloureds. S Afr Med J 1977; 52:602-606.
9. Rybicki BA, Major M, Popovich J, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 148:234-241.
10. Kanchwala AA, Barna BP, Singh RJ, et al. Deficiencies of cathelicidin and vitamin D accompany disease severity in sarcoidosis. Am J Respir Crit Care Med 2009; 179:A3997.
11. Agerberth B, Grunewald J, Castanos-Velez E, et al. Antibacterial components in bronchioalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am J Respir Crit Care Med 1999; 160:283-290.
12. Holick M. High prevalence of vitamin-D inadequacy and implications for health. Mayo Clin Proc 2006; 81:353-373.
13. Stechschulte S, Kirsner R, Federman D. Vitamin D: bone and beyond rationale and recommendations for supplementation. Am J Med 2009; 122:793-802.